OncoSil to Present at South-West Connect ASX Showcase
Filed with ASX · · 19 pages · English and French
Sydney, Australia – 18 October 2022: The Board of OncoSil Medical Ltd (ASX: OSL) (OncoSil or the Company) is pleased to announce its participation in the Canaccord Genuity South-West ASX Showcase, to be held on 19, 20 and 21 October 2022 at the Abbey Beach Resort, Busselton, Western Australia. Non-Executive Director, Brian Leedman, will be presenting at the event on Wednesday 19 October 2022 at 10
Earlier from OncoSil Medical
- Appendix 4E Announcement
- Investor Presentation
- Monthly Activities/Appendix 4C Cash Flow Report
- Patient treated in Spain proceeds to successful resection
- Bupa UK Approves Reimbursement for OncoSil in the UK
Later from OncoSil Medical
- OncoSil Receives $832k R&D Tax Incentive
- 2022 AGM CEO Presentation
- Distribution agreement signed for selected Chinese markets
- OncoSil achieves milestone of 10 patients treated in Spain
- Two key treatment centres treat first patients with OncoSil
Follow OncoSil Medical into a list and get an email when it puts out news.
Follow OncoSil Medical